INSIGHTS ON LIQUID DOSE MANUFACTURING
-
![Cytiva Microcell Vial Filler]( "Ensure Sterility In Small-Batch Drug Production")
Ensure Sterility In Small-Batch Drug ProductionAutomation and sterility are critical for small-batch drug manufacturing. Learn how robotic isolators streamline vial filling, reduce contamination risk, and support advanced therapies with precision.
-
![Aseptic Filling GettyImages-1087219366]( "A Brief History Of Aseptic Processing")
A Brief History Of Aseptic ProcessingFrom Bunsen burners to advanced isolators, aseptic processing has evolved significantly. Delve into the evolution of this crucial manufacturing method, from its early sterilization techniques to today's highly controlled and regulated environments.
-
![Cytiva's Aseptic Filling Workcell User Group]( "Cytiva's Aseptic Filling Workcell User Group")
Cytiva's Aseptic Filling Workcell User GroupDiscover how global collaboration among aseptic filling experts is driving innovation and improving operations.
-
![GettyImages-2235582013-prefilled-syringe-liquid-manufacturing]( "Ensuring Integrity: Testing Viscous Biologics In Pre-Filled Syringes")
Ensuring Integrity: Testing Viscous Biologics In Pre-Filled SyringesViscous biologics in pre-filled syringes demand precise integrity testing. Discover how advanced HVLD technology detects micro-defects and ensures sterility, meeting stringent USP <1207> standards.
-
Ready-To-Use Cartridges: Ensuring Compatibility For GLP-1-Based Drugs8/27/2024
Ready-to-use cartridges for GLP-1 applications offer safe, reliable self-administration. See how they can minimize complexities and better align with the stringent demands of modern manufacturing.
-
Jaw Crimping vs. Rotary Crimping: Enhancing Aseptic Assurance6/12/2025
Beyond a simple mechanical step, crimping is a critical control point. We examine how advanced rotary technology provides superior seal quality, particulate control, and data-driven compliance assurance.
-
A State-Of-The-Art Syringe Liquid Sampler6/24/2025
Discover a cutting-edge syringe liquid sampler for Life Sciences that offers USP <788> compliance, versatile syringe compatibility, and advanced features for precise particulate testing.
-
A Universal Workflow Approach For Single Cell Mass Spectrometry Based Proteomics11/7/2025
Learn about a streamlined workflow that improves reproducibility, reduces contamination, and simplifies single-cell proteomics with comparable results to FACS.
-
A New Approach To Isolator Decontamination4/8/2024
How can you address the decontamination challenges associated with isolated fill-finish operations? New innovations are being implemented to ensure superior sporicidal reduction and operational safety.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
![stevanato-dual]( "Dual Chamber Cartridges")
Shelf life stability is one of the key challenges for sensitive drug formulations, which have witnessed continuous growth in the past few years and are projected to grow even further in the future.
-
![3P Innovation - vibratory feeder]( "Vibratory Feeder For Powder Filling: VF1")
This versatile, compact powder filler designed to increase productivity, improve accuracy and enchance operator safety in lab and clinical manufacturing.
-
![flexiblecontainmentisolators]( "Flexible Containment Isolators")
Flexible Containment Isolators provide containment standards better than can be achieved with Downflow Booth technology, and often compare favorably with a Rigid Isolator system.
-
![iStock-657378212-vial]( "Vial Dimensional Controls")
Checking the quality of the glass forming process is crucial to reduce rejects and keep the dimensions of glass containers and their cosmetic appearance within the tight tolerances requested by pharmaceutical companies.
-
![cell and gene]( "Cell And Gene Therapy Development Aseptic R&D Filling Equipment")
Cell and gene therapies have increased in popularity in recent years, and thanks to their ability to provide one-time treatments these therapies will play a significant role in treating some of the world's most challenging diseases. These drug products treat patients afflicted with genetic disorders and cancers by targeting the source of disease and altering its genetic makeup to eliminate its cause or symptoms. These therapies are expensive and complex and have been proven effective in numerous cases, but they present a challenge in producing them at scale and at a reasonable cost.
